Chemotherapy-Induced Neuropathy Treatment in Lighthouse Point, FL
Chemotherapy-induced neuropathy is the category where we are most careful about what we say. Some of it improves with time, some responds to supportive treatment, and some reflects sensory neurons that did not survive. Evaluation establishes which parts of your picture fall where before anything is scheduled. Call (754) 547-2350 to arrange a consultation.
In plain language
Chemotherapy-Induced Neuropathy
Chemotherapy-induced peripheral neuropathy is nerve damage caused by neurotoxic cancer treatment rather than by a metabolic or mechanical process. Platinum agents damage the sensory neurons of the dorsal root ganglion, while taxanes and vinca alkaloids disrupt the microtubule transport that keeps long axons alive. The result is usually a symmetric glove-and-stocking pattern in the hands and feet that tracks with cumulative dose.
What it commonly feels like
- Numbness and tingling that appeared in the hands and feet during treatment
- Cold-triggered pain in the fingers, common after oxaliplatin
- Difficulty buttoning clothing, writing, or feeling small objects
- Burning in the soles that is worse at night
- Loss of balance from reduced position sense in the feet
What drives it
- Platinum compounds such as oxaliplatin and cisplatin
- Taxanes such as paclitaxel and docetaxel
- Vinca alkaloids and proteasome inhibitors such as bortezomib
- Cumulative dose across treatment cycles
Diagnosis first
How this cause is actually identified
The diagnosis rests on treatment history first: which agents were given, at what cumulative dose, and how the symptoms tracked against the cycles. Examination documents the glove-and-stocking distribution along with monofilament, vibration and position sense at the feet. Nerve conduction studies characterize the damage as a sensory axonal process and, more importantly, distinguish reduced amplitudes from absent potentials. We also run the deficiency workup, because B12 deficiency, thyroid dysfunction and glucose intolerance frequently coexist with CIPN and are the components that respond best.
Why Chemotherapy Damages Peripheral Nerves
Neurotoxic agents reach the peripheral nervous system through different routes depending on the drug class. Platinum compounds accumulate in the dorsal root ganglion, where the sensory neuron cell bodies sit outside the protection of the blood-brain barrier. Taxanes and vinca alkaloids interfere with the microtubule transport that long axons rely on to move materials from the cell body to the nerve ending. Both mechanisms hit the longest fibers hardest, which is why the hands and feet go first.
Timing and Coordination With Your Oncology Team
If you are still in active treatment, your oncologist leads and we coordinate around that. Antioxidant supplementation during chemotherapy remains a debated question, so infusion therapy in that window is not something we begin without your oncology team's input. After treatment is complete, that constraint changes and more of the protocol becomes available. Bring your treatment history, including agents and cumulative dose, to the consultation.
What the Protocol Targets in CIPN
Class IV laser therapy is applied over the affected nerve territories, delivering near-infrared photonic energy that increases ATP production in damaged nerve cells, reduces local neuroinflammation and supports remyelination. IV nerve-support infusions deliver vitamin B12, alpha-lipoic acid and NAD+ into circulation, bypassing the gastrointestinal absorption limits that are frequently pronounced after chemotherapy. We also test for the coexisting drivers that make CIPN worse, since B12 deficiency, thyroid dysfunction and undiagnosed glucose intolerance are common in this population and are individually correctable. Those are the parts we can act on.
Where the Ceiling Sits
A portion of CIPN improves on its own in the months after the final dose, and platinum-related symptoms can also worsen for a period after treatment ends before stabilizing. Sensory neurons destroyed in the dorsal root ganglion do not regenerate, and no conservative protocol changes that. We do not offer this as a treatment that reverses chemotherapy-induced nerve damage, because it does not. What it targets is the functional spectrum that remains, and your nerve conduction testing is what tells us how much of that there is.
Modalities typically indicated
What is usually combined for chemotherapy-induced neuropathy
The combination is selected at evaluation, not sold in advance. These are the modalities that most often apply to this root cause.
Honest expectations
What recovery can and cannot look like
This is the root cause where we are most cautious about expectations. Some CIPN improves gradually over the year or so following the last dose without any intervention, and supportive treatment during that period targets symptom burden and function. Where neurotoxic agents caused permanent structural damage, particularly after long-term or high cumulative platinum exposure, the ceiling of functional recovery is limited and no regenerative protocol overcomes it. End-stage neuropathy with absent potentials on nerve conduction studies is irreversible, and we will tell you that at consultation rather than after you have paid for a protocol.
This clinic is not an emergency service. Progressive weakness in a leg or foot, a foot that drops when you walk, numbness across the groin or inner thighs, or any new change in bowel or bladder control is a surgical emergency, with or without pain — go to an emergency department the same day rather than booking a consultation here. A foot wound that is not healing, or any other new or rapidly worsening neurological change, needs your physician rather than a treatment protocol.
Frequently Asked Questions
Can this reverse my chemotherapy-induced neuropathy?
No, and we will not tell you otherwise. Sensory neurons destroyed by neurotoxic agents do not regenerate. The protocol targets the functional spectrum that remains and any coexisting correctable driver, such as a B12 deficiency, that is compounding your symptoms.
Should I start during chemotherapy or wait until it is finished?
That decision belongs with your oncologist. Antioxidant supplementation during active chemotherapy is a debated question, so we coordinate rather than proceed independently. Supportive measures that do not raise that concern can often be discussed sooner.
It has been two years since my last infusion. Is it too late?
Not necessarily, though the natural improvement that occurs in the first year is behind you at that point. Nerve conduction testing establishes what function remains, and that result determines whether a protocol is reasonable to offer or whether we should say no.
What if my nerve conduction study shows absent responses?
Absent potentials indicate complete loss of function in those fibers, which is irreversible structural damage rather than reduced conduction. Conservative regenerative protocols do not restore complete denervation. In that situation we would not recommend starting a protocol aimed at restoring sensation.
Other root causes
Neuropathy is not one condition
Confirm whether chemotherapy-induced neuropathy is what you actually have.
Evaluation happens in clinic at 3320 N Federal Hwy, Lighthouse Point. Pricing is quoted at consultation.